FDA Convenes ALS Public Hearing February 25

01/30/2013

The Food and Drug Administration (FDA) will hold a public hearing on February 25, 2013, to allow patients, caregivers, advocates, health care providers, academia, industry, and other interested persons to give their perspectives on various aspects of the development of drugs for the treatment or management of ALS. The input from the hearing will help inform the work of the FDA offices that review applications for drugs for the treatment of ALS.

Submit your electronic or written requests for oral presentations by February 8, 2013. Submit electronic or written comments until March 25, 2013.

Click here to learn more.